The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab plus lenvatinib in women with advanced or recurrent uterine carcinosarcoma.
 
Qi Zhang
No Relationships to Disclose
 
Jubilee Brown
Consulting or Advisory Role - AstraZeneca/Merck; Genentech; Tesaro/GSK; Verastem
Speakers' Bureau - Eisai
 
Erin Crane
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
 
Yovanni Casablanca
No Relationships to Disclose
 
R. Naumann
Stock and Other Ownership Interests - Amgen
Honoraria - Johnson & Johnson/MedTech
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol-Myers Suibb; Eisai; EMD Serono; Genelux; Genmab/Seattle Genetics; GlaxoSmithKline/Tesaro; GOG Partners; Immunogen; Incyclix Bio; Laekna Therapeutics; Merck Sharp & Dohme; Nimbus Therapeutics; Seagen; Sutro Biopharma; Virtual Incision
Speakers' Bureau - Seagen
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Gynecologic Oncology Group (Inst); Mersana (Inst); OncoMed (Inst); Sutro Biopharma (Inst)